Skip to main content

Solvency II compliance could move to 2016 following latest delay

European Union red tape

The European Parliament plenary meeting to consider, and possibly approve, the Omnibus 2 amendments to the Solvency II directive has been moved back from 10 June to 22 October 2013.

While no explanation of the rationale for the delay has been offered, KPMG said this delay will allow the results of the current impact study on the impact of Solvency II on products with long-term

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Show password
Hide password

Q&A: Andy Wright, Resnova

Andy Wright, co-founder of a new consultancy firm, Resnova, speaks to Insurance Post about his time at Tesla and Zego, why he wanted to set up a consultancy firm, and why he thinks the next wave of insurtech funding could be coming from China and the Middle East.

FCA ends premium finance probe looking like a tired parent

Editor’s View: Two years after the Financial Conduct Authority kicked off about premium finance, Emma Ann Hughes feels the regulator’s market study final report felt more like finger-wagging from a worn-out parent than meaningful action from a watchdog with a powerful bite.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here